| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $5.95 (Beat by $3.97) |
| EPS GAAP Actual | $5.95 (Beat by $3.97) |
| Revenue Actual | $2.01294B |
| Revenue Surprise | Beat by $2012.94M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.65908 |
| EPS GAAP Estimate | $0.65908 |
| Revenue Estimate | $2.02817776B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 3.63 | 11.93 | 3.36689 | 3.81245 | 1 |
| Dec 2027 | 3.08 | 14.06 | 2.83366 | 3.40309 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.29 | 3.9104 | 2.01294B | -6.51% | -170.72M |
| FQ2 2025 (Jun 2025) | 0 | 0 | 1.89344B | -6.55% | 1893.44M |
| FQ1 2025 (Mar 2025) | -0.55 | -0.55 | 1.74504B | -13.51% | 1745.04M |
| FQ4 2024 (Dec 2024) | -1 | -1 | 1.83222B | -19.17% | 1832.22M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 2.14393B | -20.31% | 2143.93M |
| FQ2 2024 (Jun 2024) | 0.33 | 0.33 | 2.01747B | 11.58% | 2017.47M |
| FQ1 2024 (Mar 2024) | -0.0636 | -0.0636 | 1.98083B | 14.92% | 1980.83M |
| FQ4 2023 (Dec 2023) | 4.74 | 4.74 | 2.18351B | 100% | 2183.51M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.65908
Consensus Revenue Estimates
2.02817776B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.24553 | -- | 0.22617 | 0.26172 | 1 |
| FQ3 2027 (Sep 2027) | 1.04 | -- | 0.927 | 1.20705 | 1 |
| FQ2 2027 (Jun 2027) | 1.32 | -- | 1.17657 | 1.53203 | 1 |
| FQ1 2027 (Mar 2027) | -0.15 | -- | -0.17409 | -0.1337 | 1 |
| FQ4 2026 (Oct 2026) | 1.27158 | -- | 1.17342 | 1.39763 | 1 |
| FQ3 2026 (Jul 2026) | 1.27844 | -313.79 | 1.17975 | 1.40517 | 1 |
| FQ2 2026 (Jun 2026) | 0.67594 | -- | 0.62851 | 0.74584 | 1 |
| FQ1 2026 (Mar 2026) | 0.65908 | 183.45 | 0.61283 | 0.72724 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.91B | -- | 1.8B | 2.01B | 2 |
| FQ3 2027 (Sep 2027) | 3.68B | -- | 3.37B | 4.14B | 2 |
| FQ2 2027 (Jun 2027) | 3.45B | -- | 3.17B | 3.88B | 2 |
| FQ1 2027 (Mar 2027) | 3.24B | -- | 2.97B | 3.64B | 2 |
| FQ4 2026 (Oct 2026) | 2.07B | -- | 1.95B | 2.23B | 1 |
| FQ3 2026 (Jul 2026) | 2.05B | 1.76 | 1.93B | 2.21B | 1 |
| FQ2 2026 (Jun 2026) | 2.05B | 7.59 | 1.94B | 2.21B | 1 |
| FQ1 2026 (Mar 2026) | 2.03B | 13.96 | 1.92B | 2.19B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
3
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.3796 | 5.29 | 3.9104 | 73.92% |
| FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | -0.55 | -0.55 | 100% | |
| FQ4 2024 (Dec 2024) | -1 | -1 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.33 | 0.33 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0636 | -0.0636 | 100% | |
| FQ4 2023 (Dec 2023) | 4.74 | 4.74 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.18B | $2.01B | $-170.72M | -8.48% |
| FQ2 2025 (Jun 2025) | $0B | $1.89B | $1893.44M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.75B | $1745.04M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.83B | $1832.22M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.14B | $2143.93M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.02B | $2017.47M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.98B | $1980.83M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.18B | $2183.51M | 100% |